Prana Biotechnology Limited (NASDAQ:PRAN)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $1.60 and last traded at $1.60, with a volume of 150 shares traded. The stock had previously closed at $1.77.
Separately, ValuEngine raised shares of Prana Biotechnology from a “hold” rating to a “buy” rating in a research report on Thursday, November 1st.
COPYRIGHT VIOLATION NOTICE: “Prana Biotechnology (PRAN) Sets New 12-Month Low at $1.60” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/10/prana-biotechnology-pran-sets-new-12-month-low-at-1-60.html.
Prana Biotechnology Company Profile (NASDAQ:PRAN)
Prana Biotechnology Ltd. engages in the development of therapy treatment for neurodegenerative disease. It includes research and development of treatments for Alzheimer’s and Huntington’s disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.
Further Reading: Hedge Funds Explained
Receive News & Ratings for Prana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.